Teresa Herlevi, PA
Medical · Myrtle Beach, SCNPI 1801172390
Payments from drug & device makers
Across 58 payments — averaging $25.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$191
- Incyte Corporation$156
- Gilead$135
- Pfizer$120
- Daiichi Sankyo Inc.$120
- Genentech USA, Inc.$109
- plus $635 from 17 others
What the payments were for
- Food & beverage$1,33591%
- Education$1319%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 7 | $191 |
| Incyte Corporation | 4 | $156 |
| Gilead | 5 | $135 |
| Pfizer | 6 | $120 |
| Daiichi Sankyo Inc. | 5 | $120 |
| Genentech USA, Inc. | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 4 | $83 |
| Genmab U.S., Inc. | 2 | $60 |
| AstraZeneca(2 entities) | 3 | $60 |
| Novartis | 2 | $52 |
| Bayer | 2 | $52 |
| Tersera Therapeutics LLC | 2 | $42 |
| Sanofi | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Eisai Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 1 | $26 |
| Bristol Myers Squibb | 1 | $25 |
| ADC Therapeutics America, Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $23 |
| Beone Medicines USA, Inc. | 1 | $23 |
| Acrotech Biopharma Inc. | 1 | $21 |
| AbbVie | 1 | $21 |
How this compares
$1,466 in reported general payments places this provider in the 60th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 14 | $126 |
Paid to pharmacies, not to this prescriber.
Other medical in Myrtle Beach
- Lindsay JohnsonMyrtle Beach$11K
- Bleselda ParagasMyrtle Beach$8K
- Tanya BralleyMyrtle Beach$7K
- Sanford HardinMyrtle Beach$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.